thrombotic


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to thrombotic: thrombotic thrombocytopenic purpura, thrombotic microangiopathy, Thrombotic stroke

throm·bot·ic

(throm-bot'ik),
Relating to, caused by, or characterized by thrombosis.

thrombotic

/throm·bot·ic/ (-bot´ik) pertaining to or affected with thrombosis.

throm·bot·ic

(throm-bot'ik)
Relating to, caused by, or characterized by thrombosis.

thrombotic

pertaining to or emanating from thrombosis.

thrombotic meningoencephalitis

Patient discussion about thrombotic

Q. How can I prevent blood clots? I am 45 years old and am supposed to go on a business trip overseas. The flight itself is 12 hours long and then I have to continue traveling by bus. Could this cause me to have blood clots? If so, how can I prevent it?

A. Always walk as much as you can on the plane. Also, rotate your ankels in circles. Sometimes try to use your ankels and make the alphabet with them. Have fun..

More discussions about thrombotic
References in periodicals archive ?
Pulmonary tumor thrombotic microangiopathy from metastatic epithelioid angiosarcoma.
Therefore, we initially suspected that the mechanism of the digital embolic was thrombotic in nature, secondary to the radial arterial catheter.
3%) with APS with recurrent spontaneous abortion had thrombotic events over the study period, including four cerebral arterial infarctions, one cerebellar arterial infarction, and two deep vein thromboses, pulmonary embolisms, and ischemic myocardial infarctions each.
INDEX TERMS: ADAMTS-13; hemolytic-uremic syndrome; microangiopathic hemolytic anemia; schistocytes; thrombotic microangiopathy; thrombotic thrombocytopenic purpura.
ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.
Thrombotic thrombocytopenic purpura can be classified into different types, based predominantly on age at onset and clinical course.
Hemostasis and Thrombosis comprehensively reviews the physiology and biochemistry of hemostasis and the pathophysiology of thrombosis as well as the diagnosis and treatment of bleeding and thrombotic disorders.
The characteristics of the first thrombotic episode in the 34 subjects with the FVL mutation alone and 18 subjects with the prothrombin mutation alone are summarized in Table 2.
However, Zafgen failed to disclose to investors at that time that the patient was receiving beloranib (not a placebo), and further failed to disclose news about thrombotic events in prior clinical trials of beloranib.
Evidence of an increased in vitro thrombotic tendency in patients with reactive thrombocytosis is of paramount importance in proving the cause and effect relationship between reactive thrombocytosis and thromboembolism.
Preliminary results from two large ongoing epidemiologic studies evaluating the safety of the Ortho Evra contraceptive patch provided conflicting data on whether the risk of thrombotic events might be greater with the patch than with oral contraceptive pills.
Last month, the manufacturer, Ortho Women's Health and Urology, announced preliminary results of the two studies, which compare thrombotic event rates in women on Ortho Evra and women on an oral contraceptive pill containing norgestimate with 35 mcg of ethinyl estradiol.